Examining the role of molecular imaging in prostate cancer from staging through biochemical recurrence with Dr. Louis Mazzarelli, Director of Molecular Imaging at Lawrence and Memorial and Westerly Hospitals with Yale New Haven Health.
Examining the role of molecular imaging in lung cancer from initial diagnosis through post-therapy follow-up with Dr. Ryan Avery, Associate Professor of Cardiovascular Imaging & Nuclear Medicine, Director of Nuclear Medicine, and Director of Advanced Imaging & Analytics Laboratory in the Department of Radiology at Northwestern Medicine.
Integration of SPECT/CT imaging and radionuclide therapy for an ever-increasing spectrum of cancers points to a promising future for such therapies. Explore this white paper and discover how accurate quantification of tracer concentration with SPECT/CT is potentially key to dosimetry and optimal therapy outcomes.
White paper: IQ•SPECT - a technical and clinical overview
This white paper briefly explains the technical aspects of IQ•SPECT and demonstrates normal patterns and variations, as well as shows a series of clinical examples of ischemia and infarction.
This case highlights the utility of tumor and organ dosimetry from sequential quantitative SPECT/CT in metastatic prostate cancer.
This case demonstrates the value of 82Rb myocardial perfusion PET/CT and blood flow estimation in the delineation of multivessel CAD and post-therapy stent occlusion.